World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
71
Citations
20028
World Ranking
2299
National Ranking
88

Hendrika Bootsma publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Hendrika Bootsma sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 450 publications — 86th percentile

86% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Hendrika Bootsma D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Hendrika Bootsma sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 71 D-Index — 54th percentile

54% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Hendrika Bootsma is affiliated with the University Medical Center Groningen in the Netherlands. Their research primarily focuses on topics related to salivary gland disorders and functions, with significant contributions in related areas such as salivary gland tumors diagnosis and treatment, systemic lupus erythematosus research, and systemic sclerosis and related diseases.

Their work spans various fields of study within medicine, particularly emphasizing subfields like physiology, rheumatology, surgery, immunology, and pathology and forensic medicine. The integration of these disciplines reflects a comprehensive approach to understanding disease mechanisms and treatment modalities, especially in autoimmune and glandular conditions.

Key topics addressed in their publications include:

  • Salivary Gland Disorders and Functions
  • Salivary Gland Tumors Diagnosis and Treatment
  • Systemic Lupus Erythematosus Research
  • Systemic Sclerosis and Related Diseases
  • Oral Health Pathology and Treatment
  • Spondyloarthritis Studies and Treatments
  • Monoclonal and Polyclonal Antibodies Research

Hendrika Bootsma has contributed to numerous papers, with some notable recent publications including:

  • 2021 DORIS definition of remission in SLE: final recommendations from an international task force (2021, Lupus Science & Medicine)
  • Epithelial-immune cell interplay in primary Sjögren syndrome salivary gland pathogenesis (2021, Nature Reviews Rheumatology)
  • Efficacy and safety of abatacept in active primary Sjögren's syndrome: results of a phase III, randomised, placebo-controlled trial (2020, Annals of the Rheumatic Diseases)
  • A randomized, phase II study of sequential belimumab and rituximab in primary Sjögren's syndrome (2022, JCI Insight)
  • The Transcriptome of Paired Major and Minor Salivary Gland Tissue in Patients With Primary Sjögren's Syndrome (2021, Frontiers in Immunology)

The scientist frequently collaborates with a consistent group of coauthors, including Suzanne Arends, Frans G. M. Kroese, Arjan Vissink, Gwenny M. Verstappen, and Fred K. L. Spijkervet, indicating a collaborative research environment and shared interests in rheumatology and immunological studies.

Hendrika Bootsma's research output is often published in established venues such as Annals of the Rheumatic Diseases, Lara D. Veeken, Clinical and Experimental Rheumatology, PubMed, and The Journal of Rheumatology. These venues reflect a strong connection to rheumatologic and clinical research communities, with an emphasis on peer-reviewed dissemination of findings relevant to autoimmune and salivary gland diseases.

Their extensive publication record in these journals and specialized fields of medicine showcases an ongoing commitment to advancing knowledge in the mechanisms, diagnosis, and treatment of complex autoimmune and glandular conditions.

Best Publications

  • Treat-to-target in systemic lupus erythematosus: recommendations from an international task force

    Ronald van Vollenhoven;Marta Mosca;George Bertsias;David Isenberg

  • Rituximab treatment in patients with primary Sjögren's syndrome: an open-label phase II study.

    J Pijpe;van Gustaaf Imhoff;Frederik Spijkervet;Jan Roodenburg

  • EULAR Sjögren's syndrome disease activity index (ESSDAI): a user guide.

    Raphaèle Seror;Simon J Bowman;Pilar Brito-Zeron;Elke Theander

  • Prevention of relapses in systemic lupus erythematosus.

    H. Bootsma;P. Spronk;G. de Boer;P. Limburg

  • A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS)

    Ronald van Vollenhoven;Alexandre Voskuyl;George Bertsias;Cynthia Aranow

  • Characterization of systemic disease in primary Sjögren's syndrome: EULAR-SS Task Force recommendations for articular, cutaneous, pulmonary and renal involvements

    Manuel Ramos-Casals;Pilar Brito-Zerón;Raphaèle Seror;Hendrika Bootsma

  • Health-related quality of life, employment and disability in patients with Sjögren's syndrome

    Jiska M. Meijer;Petra M. Meiners;James J. R. Huddleston Slater;Fred K. L. Spijkervet

  • Skewed distribution of IgG Fc receptor IIa (CD32) polymorphism is associated with renal disease in systemic lupus erythematosus patients

    A J Duits;H Bootsma;R H Derksen;P E Spronk

  • Epithelial-immune cell interplay in primary Sjögren syndrome salivary gland pathogenesis.

    Gwenny M Verstappen;Sarah Pringle;Hendrika Bootsma;Frans G M Kroese

  • Parotid gland biopsy compared with labial biopsy in the diagnosis of patients with primary Sjogren's syndrome

    J. Pijpe;Warner Kalk;J. E. van der Wal;Arjan Vissink

  • CHANGES IN ANTIBODIES TO C1Q PREDICT RENAL RELAPSES IN SYSTEMIC LUPUS-ERYTHEMATOSUS

    Ida E.M. Coremans;Peter E. Spronk;Hendrika Bootsma;Mohamed R. Daha

  • Influence of geolocation and ethnicity on the phenotypic expression of primary Sjögren's syndrome at diagnosis in 8310 patients: a cross-sectional study from the Big Data Sjögren Project Consortium.

    Pilar Brito-Zerón;Pilar Brito-Zerón;Nihan Acar-Denizli;Margit Zeher;Astrid Rasmussen

  • Shared gut, but distinct oral microbiota composition in primary Sjögren's syndrome and systemic lupus erythematosus.

    Taco A. van der Meulen;Hermie J.M. Harmsen;Arnau Vich Vila;Alexander Kurilshikov

  • Levels of soluble VCAM‐1, soluble ICAM‐1, and soluble E‐selectin during disease exacerbations in patients with systemic lupus erythematosus (SLE); a long term prospective study

    P. E. Spronk;H. Bootsma;M. G. Huitema;P. C. Limburg

  • Th17 cells in primary Sjogren's syndrome : Pathogenicity and plasticity

    Gwenny M. Verstappen;Odilia B.J. Corneth;Hendrika Bootsma;Frans G.M. Kroese

  • Attenuation of Follicular Helper T Cell-Dependent B Cell Hyperactivity by Abatacept Treatment in Primary Sjogren's Syndrome

    Gwenny M. Verstappen;Petra M. Meiners;Odilia B. J. Corneth;Annie Visser

  • Is salivary gland ultrasonography a useful tool in Sjögren’s syndrome? A systematic review

    Sandrine Jousse-Joulin;Vera Milic;Malin V Jonsson;Athena Plagou

  • Sialometry and sialochemistry: diagnostic tools for Sjögren's syndrome

    Wwi Kalk;Arjan Vissink;Frederik Spijkervet;Hendrika Bootsma

  • B-cell hyperactivity in primary Sjögren's syndrome

    Franciscus Kroese;Wayel H Abdulahad;Erlin Haacke;Nicolaas A Bos

  • The microbiome-systemic diseases connection

    van der Taco Meulen;Hermie Harmsen;Hendrika Bootsma;Frederik Spijkervet

  • Early diagnosis of primary Sjögren’s syndrome: EULAR-SS task force clinical recommendations

    Pilar Brito-Zerón;Elke Theander;Chiara Baldini;Raphaèle Seror

  • The predictive value of fluctuations in IgM and IgG class anti-dsDNA antibodies for relapses in systemic lupus erythematosus. A prospective long term observation

    H. Bootsma;P.E. Spronk;E.J. Terborg;E.J. Hummel

  • How immunological profile drives clinical phenotype of primary Sjögren's syndrome at diagnosis: analysis of 10,500 patients (Sjögren Big Data Project).

    Pilar Brito-Zerón;Nihan Acar-Denizli;Wan-Fai Ng;Margit Zeher

Frequent Co-Authors

Arjan Vissink
Arjan Vissink University Medical Center Groningen
Frans G. M. Kroese
Frans G. M. Kroese University Medical Center Groningen
Elisabeth Brouwer
Elisabeth Brouwer University Medical Center Groningen
Xavier Mariette
Xavier Mariette University of Paris-Saclay
Manuel Ramos-Casals
Manuel Ramos-Casals Hospital Clinic of Barcelona
Michele Bombardieri
Michele Bombardieri Queen Mary University of London
Cees G. M. Kallenberg
Cees G. M. Kallenberg University of Groningen
David A. Isenberg
David A. Isenberg University College London
Damien Sene
Damien Sene Université Paris Cité
Luca Quartuccio
Luca Quartuccio University of Udine

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in expanding their knowledge in Immunology, numerous related online degrees offer flexible and affordable options. Programs such as affordable pmhnp programs provide accessible routes for professionals looking to specialize in mental health nursing while balancing cost and quality of education.

Advancing in healthcare careers often involves choosing a specialty with strong job prospects and competitive salaries. According to data on the highest paid dnp specialties, nurse practitioners with Doctor of Nursing Practice degrees in acute care and psychiatric mental health tend to command higher compensation, reflecting demand in these critical fields.

Transitioning between nursing roles is a common pathway for career growth. Those considering a shift can explore programs designed to help with the transition, such as from fnp to acute care np, enabling nurses to extend their expertise into more specialized acute and critical care settings.

For individuals eager to accelerate their career progression, accelerated np program options offer streamlined paths to becoming nurse practitioners. These programs are designed to reduce time-to-degree without compromising educational standards, providing a rapid route to enter advanced practice roles in healthcare.

Best Scientists Citing Hendrika Bootsma

Trending Scientists

Recently Published Articles